Usman Waheed/LinkedIn
Sep 12, 2026, 17:53
Usman Waheed: Introducing the Discovery of the 49th ISBT Blood Group System
Usman Waheed, Managing Editor of Journal of Islamabad Medical and Dental College, shared on LinkedInΒ about a recent article by Tosti J. Mankelow et al., published in Vox Sanguinis, adding:
“Introducing the discovery of the 49th ISBT Blood Group System.
The discovery is credited to the International Blood Group Reference Laboratory, NHS Blood and Transplant, Bristol, UK.”
Title: Identification of a novel high-prevalence red blood cell antigen on junctional adhesion molecule-A defines a new blood group system
Authors: Tosti J. Mankelow, Louise A. Tilley, Vanja Karamatic Crew, Benjamin Jones, Marina Izak, Liora Muncher, Vered Yahalom, Nicole M. Thornton

Stay updated on all scientific advnaces with Hemostasis Today.
49th ISBT Blood Group System
Benjamin Jones
Blood
Blood group
Health
Hematology
Hemostasis
Hemostasis News
Hemostasis Today
International Blood Group Reference Laboratory
ISBT
Liora Muncher
Louise A Tilley
Marina Izak
Medicine
NHS Blood and Transplant
Nicole M Thornton
RBC
πΏπ²π± π―πΉπΌπΌπ± π°π²πΉπΉπ
Tosti J Mankelow
UK
Usman Waheed
Vanja Karamatic Crew
Vered Yahalom
Vox Sanguinis
-
Sep 12, 2026, 17:51Maria Sabater Lleal: Happy to Share Our Latest Work Exploring the Genetic Determinants of PE in VTE
-
Sep 12, 2026, 17:51Jeff Sternlicht: Why LDL-C and ApoB Remain King of the Hill?
-
Sep 12, 2026, 17:49Kalyan Roy: TRAGS – An Emerging Transfusion Safety Concern
-
Sep 12, 2026, 17:48Jason Fung: What Happened to “Statins Save Lives”?
-
Sep 12, 2026, 17:47Eric Topol: Most Supplements and Vitamins Offer Little Proven Benefit
-
Sep 12, 2026, 17:44Manuel Monreal: Clinical Characteristics, Treatment, and Outcomes in Hispanic vs Caucasian Patients With VTE
-
Sep 12, 2026, 17:43Sidi Mohamed El Amine Benlazar: CPX-351 and Ruxolitinib in Advanced-Phase Myeloproliferative Neoplasms
-
Sep 12, 2026, 17:42Elad Asher: Higher IPF Is Associated with Adverse Outcomes in ICCU
-
Sep 12, 2026, 16:40Heghine Khachatryan: From Ideal Protocols to Feasible Pathways in Hemophilia Musculoskeletal Care